News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Emmanuel Antonarakis Highlights HOXB13 Mutation Linked to Prostate Cancer Risk and Hormonal Therapy Sensitivity
Emmanuel S. Antonarakis/med.umn.edu
Jun 23, 2025, 05:22

Emmanuel Antonarakis Highlights HOXB13 Mutation Linked to Prostate Cancer Risk and Hormonal Therapy Sensitivity

Emmanuel Antonarakis, Clark Endowed Professor of Medicine at Masonic Cancer Center, University of Minnesota, shared on X about a recent paper by Mayuko Kanayama et al. published in Nature:

“A novel west-African germline founder mutation in HOXB13 (p.X285Kext) increases risk of high-grade prostate cancer but also enhances sensitivity to hormonal therapy. Congrats to PCF-funded Mayuko Kanayama”

Title: Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant

Authors: Mayuko Kanayama, Emeline Colomba, Yusra Shao, Sarah M. Nielsen, Edward D. Esplin, Changxue Lu, William B. Isaacs, John C. Henegan, Elisabeth I. Heath, Jun Luo, Régine Marlin and Emmanuel S. Antonarakis

Read Full Article.

Emmanuel Antonarakis

More posts featuring Emmanuel Antonarakis on OncoDaily.

cancer cancer risk Changxue Lu Edward D. Esplin Elisabeth I. Heath Emeline Colomba Emmanuel S Antonarakis John C. Henegan Jun Luo Mayuko Kanayama OncoDaily Oncology prostate cancer Régine Marlin Sarah M. Nielsen William B. Isaacs Yusra Shao
Special Coverage
Blog
Jun 23, 2025, 09:26
Sakditad Saowapa Shares ISTH 2025 Highlights on TPO-RAs and Chemotherapy-Induced Thrombocytopenia
Blog
Jun 23, 2025, 09:19
Pavlos Msaouel: Misinterpretation of ASSURE Nomogram in Kidney Cancer Follow-Up
Blog
Jun 23, 2025, 09:11
Estela Rodriguez Honors Luis Delgado Mateu for Compassionate Cancer Care in Puerto Rico
Blog
Jun 23, 2025, 09:05
Cancer Discovery - Tumor Promoters and Tissue Damage Reactivate Dormant Mutated Cells in Mouse Skin
Blog
Jun 23, 2025, 08:55
Nick Mark: NaPathway - Safe Hyponatremia Correction Tool
Blog
Jun 23, 2025, 08:55
Corey Speers Highlights UAB Radiation Oncology’s Innovation at Wolfsberg Meeting
Blog
Jun 23, 2025, 08:42
Samuel Badalian Highlights Armenian Fellows Urogynecology Debut at IUGA in Barcelona
Blog
Jun 23, 2025, 08:38
Trish Boh: Reflecting on National Cancer Survivors Day and the Strength of Survivorship
Blog
Jun 23, 2025, 08:19
Anwaar Saeed Celebrates STELLAR-303 as First IO Trial Showing OS Benefit in MSS Colorectal Cancer
Blog
Jun 23, 2025, 08:05
Thor Halfdanarson Highlights Rachel Eiring’s NCAN Presentation on Patient Empowerment
Blog
Jun 23, 2025, 07:59
Julie Gralow: Pleased to Participate in Best of ASCO UAE 2025 Conference
Dialogues
Jun 23, 2025, 07:58
TOP Biotechs at ASCO: Matt McLoughlin on Launching Clinical Lab Navigator and Trial Insights Platform